Karin P S Langenberg-Ververgaert

13PUBLICATIONS
165CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeonatologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Mar 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Yvette A H Matser, André B P van Kuilenburg, Atia Samim

|Jan 28, 2026
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Rixt S Bruinsma, Wendy W J de Leng, Marta F Fiocco

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Feb 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Yvette A H Matser, Atia Samim, Marta Fiocco

|Jan 11, 2025
Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.

Rixt S Bruinsma, Caroline W M Lekkerkerker, Marta Fiocco

Pageof 3

Frequent Collaborators

5 joint publications

Godelieve Tytgat

4 joint publications

Max M van Noesel

4 joint publications

Marta Fiocco

3 joint publications

Ruth Witt